Literature DB >> 27738074

Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.

Newton B Wiggins1, Daniel T Chong1, Penny L Houghtaling2, Ayman A Hussein1, Walid Saliba1, Joseph F Sabik3, Oussama Wazni1, Bruce L Wilkoff1, Khaldoun G Tarakji1.   

Abstract

AIMS: The incidence, indications, and risk factors for cardiac implantable electronic device (CIED) implantation after cardiac surgery in an era with an aging population are not well described. There are limited data about the survival of these patients compared with a non-device group. We aimed to evaluate the incidence, indications, and risk factors for postoperative CIED implantation. We also assessed survival of these patients compared with a non-device group.
METHODS: We included all patients without prior CIED implantation who underwent cardiac surgery at our institution from 1996 to 2008. Characteristics associated with CIED implantation were identified by multivariable logistic regression. A propensity model was constructed to compare survival.
RESULTS: A total of 39 546 patients were included in the study of which 1608 patients (4.1%) underwent postoperative CIED implantation. Conduction disease accounted for most devices, but 371 patients underwent CIED implantation for secondary prevention of ventricular arrhythmias. Risk factors associated with implantation included older age, valvular disease, atrial fibrillation, and prior surgery. The propensity-adjusted risk of early death (within 1 year) was significantly less in the device group (hazard ratio [HR] 0.38; 95% confidence interval [CI] 0.22-0.65; P = 0.0004). However, the propensity-adjusted risk of late death was significantly greater in the device group (HR 1.3; 95% CI 1.2-1.5; P = <0.0001).
CONCLUSION: Despite an aging population, the incidence of CIED implantation after cardiac surgery remains low and varies by the type of operation. Follow-up suggests increased early survival but decreased late survival in patients who undergo CIED implantation compared with a non-device group. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac surgery; Implantable cardioverter-defibrillator; Implantation rate; Mortality; Patient characteristics; Permanent pacemaker

Mesh:

Year:  2017        PMID: 27738074     DOI: 10.1093/europace/euw234

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Evaluation of right ventricular pacing parameters in patients with proliferative scar.

Authors:  Veysel Kutay Vurgun; Emir Baskovski; Huseyin Goksuluk; Nil Ozyuncu; Turkan Seda Tan; Ali Timucin Altin; Basar Candemir; Omer Akyurek
Journal:  J Interv Card Electrophysiol       Date:  2018-06-13       Impact factor: 1.900

2.  Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.

Authors:  Gil Moskowitz; Kimberly N Hong; Gennaro Giustino; A Marc Gillinov; Gorav Ailawadi; Joseph J DeRose; Alexander Iribarne; Alan J Moskowitz; Annetine C Gelijns; Natalia N Egorova
Journal:  J Am Coll Cardiol       Date:  2019-11-26       Impact factor: 24.094

3.  Permanent pacemaker implantation after On-X surgical aortic valve replacement: SWEDEHEART observational study.

Authors:  Magnus Dalén; Michael Persson; Natalie Glaser; Ulrik Sartipy
Journal:  BMJ Open       Date:  2021-11-18       Impact factor: 2.692

4.  Permanent pacemaker placement following valve surgery is not independently associated with worse outcomes.

Authors:  Valentino Bianco; Arman Kilic; Edgar Aranda-Michel; Derek Serna-Gallegos; Courtenay Dunn-Lewis; Shangzhen Chen; Floyd Thoma; Forozan Navid; Ibrahim Sultan
Journal:  JTCVS Open       Date:  2021-06-16

5.  Long-term Outcomes Associated With Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement.

Authors:  Natalie Glaser; Michael Persson; Magnus Dalén; Ulrik Sartipy
Journal:  JAMA Netw Open       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.